How do doctors decide when to use standard chemotherapy, explore immunotherapy, or recommend a clinical trial? In this episode of PancChat, host Alisyn Camerota speaks with Dr. Andrew Hendifar about how tumor sequencing, genetic testing, and emerging KRAS-targeted therapies are reshaping pancreatic cancer care. They discuss the challenges patients face navigating clinical trials, why timing and advocacy are critical, and why — despite the daunting diagnosis — there’s more reason for hope today than ever before.

Dr. Andrew Hendifar heads the Gastrointestinal Disease Research Group and founded their Hematology and Oncology Fellowship Program at Cedars-Sinai Medical Center in Los Angeles. He works with SWOG and the NIH’s Neuroendocrine Tumor Task Force., Dr. Hendifar is a member of PanCAN’s Scientific and Medical Advisory Board.

Learn more about how clinical trials work on the Let’s Win What Is a Clinical Trial? Page or PanCAN’s Clinical Trials page.

You can explore available clinical trials through the Let’s Win’s Trial Finder or the PanCAN Clinical Trial Finder.

For a personalized search, PanCAN’s Patient Services is also here to help.